CCTG584: Viral dynamics and pharmacokinetics of tenofovir and abacavir monotherapy versus the combination therapy of TDF [tenofovir disoproxil fumarate]-ABC [abacavir] in HIV-infected treatment naive patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Abacavir; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 09 Mar 2021 Biomarkers information updated
- 02 Aug 2011 Actual end date Feb 2009 added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.